PROTAGONIST THERAPEUTICS
Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.
PROTAGONIST THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2001-01-01
Address:
Brisbane, Queensland, Australia
Country:
Australia
Website Url:
http://www.protagonist-inc.com
Total Employee:
101+
Status:
Active
Contact:
61 7 3346 2975
Email Addresses:
[email protected]
Total Funding:
388.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics ReCAPTCHA
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Venatorx Pharmaceuticals
Venatorx Pharmaceuticals develops a novel anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Protagonist Therapeutics
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Protagonist Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Protagonist Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Protagonist Therapeutics
Adage Capital Management
Adage Capital Management investment in Series C - Protagonist Therapeutics
Canaan Partners
Canaan Partners investment in Series C - Protagonist Therapeutics
Pharmstandard International
Pharmstandard International investment in Series C - Protagonist Therapeutics
Starfish Ventures
Starfish Ventures investment in Series C - Protagonist Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Protagonist Therapeutics
Inbio Ventures
Inbio Ventures investment in Series C - Protagonist Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-28 | Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President and Chief Financial Officer |
Official Site Inspections
http://www.protagonist-inc.com Semrush global rank: 3.4 M Semrush visits lastest month: 4.6 K
- Host name: 172.67.72.193
- IP address: 172.67.72.193
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
